[Parenteral S-adenosylmethionine compared to placebos in the treatment of alcoholic liver diseases].
The improvements in the knowledge of the action of ethanol over the hepatic cell, its direct action over the cell, and the intracytoplasmatic structures membranes, point out the possibilities of use of sulfo-adenosil-L-metionina (SAMe); as an util drug inn the treatment of the altered metilation reactions, that take place in those membranes, facilitating their physiological functions. The primary end point in this study was to demonstrate the therapeutic worth os SAMe, by parenteral route in 45 patients with alcoholic liver disease, which were determined by clinical laboratory and hepatic function test, label qith 32 points or more of the discriminatory function index. Divided into two groups, placebo-SAMe, randomized, double blind. As well as total plasmatic and reduced glutation and lipoperoxidation index, indirect form as malondehaldehyde. Were determined at the first visit anf after 8 and 15 days of treatment. Comparing the results of both groups there were a significative favorable results for the group treatment with SAMe and this confirms the utility of this drug in the treatment of patients with alcoholic liver disease with a discriminatory function index (Maddrey index), of 32 points or more.
Diaz Belmont
A
A
Clínica para la Atención a Problemas Relacionados con el Alcohol, Hospital General de México, S.Sa.
Dominguez Henkel
R
R
Uribe Ancira
F
F
D000328:Adult; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008108:Liver Diseases, Alcoholic / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011446:Prospective Studies; D012436:S-Adenosylmethionine / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors
D010919:Placebos; D012436:S-Adenosylmethionine
SAMe parenteral en el tratamiento de la hepatopatía alcohólica comparativo contra placebo.